BriaCell Therapeutics Corp. (OTCMKTS:BCTXF – Get Free Report) shot up 13.6% during trading on Tuesday . The company traded as high as $4.45 and last traded at $4.35. 286,995 shares were traded during mid-day trading, an increase of 15,338% from the average session volume of 1,859 shares. The stock had previously closed at $3.83.
BriaCell Therapeutics Stock Up 13.6 %
The stock has a market capitalization of $3.36 million, a P/E ratio of -0.01 and a beta of 1.09. The firm has a fifty day moving average price of $1.66 and a two-hundred day moving average price of $1.08.
BriaCell Therapeutics Company Profile
BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.
Recommended Stories
- Five stocks we like better than BriaCell Therapeutics
- Using the MarketBeat Dividend Yield Calculator
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Investing In Automotive Stocks
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- ESG Stocks, What Investors Should Know
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
